{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:10:54Z","timestamp":1790820654504,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["Ricerca Locale 2016-2017"],"award-info":[{"award-number":["Ricerca Locale 2016-2017"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["FFABR 2018"],"award-info":[{"award-number":["FFABR 2018"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00592-019-01403-9","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T18:02:31Z","timestamp":1565632951000},"page":"1283-1292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies"],"prefix":"10.1007","volume":"56","author":[{"given":"Elisabetta","family":"Muntoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Milla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Gh\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bargoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Capucchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Biasibetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5081-3638","authenticated-orcid":false,"given":"Luigi","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,12]]},"reference":[{"issue":"12","key":"1403_CR1","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1185\/030079906X154178","volume":"22","author":"GE Peterson","year":"2006","unstructured":"Peterson GE (2006) Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir. Curr Med Res Opin 22(12):2613\u20132619","journal-title":"Curr Med Res Opin"},{"key":"1403_CR2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0169-409X(98)00039-8","volume":"34","author":"E Alleman","year":"1998","unstructured":"Alleman E, Leroux JC, Gurny R (1998) Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics. Adv Drug Del Rev 34:171\u2013187","journal-title":"Adv Drug Del Rev"},{"issue":"S2","key":"1403_CR3","first-page":"15","volume":"4","author":"M Mutalik","year":"2011","unstructured":"Mutalik M (2011) Long awaited dream of oral insulin: Where did we reach? Asian J Pharm Clin Res 4(S2):15\u201320","journal-title":"Asian J Pharm Clin Res"},{"key":"1403_CR4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0169-409X(01)00152-1","volume":"50","author":"NH Hussain","year":"2001","unstructured":"Hussain NH, Jaitley V, Florence A (2001) Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas. Adv Drug Del Rev 50:107\u2013142","journal-title":"Adv Drug Del Rev"},{"issue":"2","key":"1403_CR5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/10611860410001693706","volume":"12","author":"A Florence","year":"2004","unstructured":"Florence A (2004) Issues in oral nanoparticle drug carrier uptake and targeting. J Drug Target 12(2):65\u201370","journal-title":"J Drug Target"},{"key":"1403_CR6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0169-409X(01)00151-X","volume":"50","author":"CJ Porter","year":"2001","unstructured":"Porter CJ, Charman WN (2001) Intestinal lymphatic drug transport: an update. Adv Drug Del Rev 50:61\u201380","journal-title":"Adv Drug Del Rev"},{"key":"1403_CR7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0169-409X(96)00494-2","volume":"25","author":"AJ Humberstone","year":"1997","unstructured":"Humberstone AJ, Charman WN (1997) Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Del Rev 25:103\u2013128","journal-title":"Adv Drug Del Rev"},{"key":"1403_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","volume":"50","author":"RH M\u00fcller","year":"2000","unstructured":"M\u00fcller RH, M\u00e4der K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery\u2014a review of the state of the art. Eur J Pharm Biopharm 50:161\u2013177","journal-title":"Eur J Pharm Biopharm"},{"issue":"7","key":"1403_CR9","first-page":"1848","volume":"4","author":"N Jawahar","year":"2012","unstructured":"Jawahar N, Meyyanathan SN, Reddy G, Sood S (2012) Solid lipid nanoparticles for oral delivery of poorly soluble drugs. J Pharm Sci & Res 4(7):1848\u20131855","journal-title":"J Pharm Sci & Res"},{"key":"1403_CR10","first-page":"1","volume-title":"Advances in drug research","author":"S Muranishi","year":"1991","unstructured":"Muranishi S (1991) Drug targeting towards the lymphatics. In: Testa B (ed) Advances in drug research, vol 21. Academic Press, London, pp 1\u201338"},{"key":"1403_CR11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.colsurfb.2007.03.002","volume":"58","author":"H Yuan","year":"2007","unstructured":"Yuan H, Chen J, Du Y-Z, Hu FQ, Zeng S, Zhao HL (2007) Studies on oral absorption of stearic acid SLN by a novel fluorometric method. Colloids Surf B 58:157\u2013164","journal-title":"Colloids Surf B"},{"key":"1403_CR12","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0169-409X(02)00118-7","volume":"54","author":"RH M\u00fcller","year":"2002","unstructured":"M\u00fcller RH, Radtke M, Wissing A (2002) Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Del Rev 54:S131\u2013S155","journal-title":"Adv Drug Del Rev"},{"issue":"5","key":"1403_CR13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1517\/17425247.2012.673278","volume":"9","author":"L Battaglia","year":"2012","unstructured":"Battaglia L, Gallarate M (2012) Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery. Expert Opin Drug Del 9(5):497\u2013508","journal-title":"Expert Opin Drug Del"},{"key":"1403_CR14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.addr.2007.04.007","volume":"59","author":"AJ Almeida","year":"2007","unstructured":"Almeida AJ, Souto E (2007) Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Del Rev 59:478\u2013490","journal-title":"Adv Drug Del Rev"},{"key":"1403_CR15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/02652040903031279","volume":"27","author":"L Battaglia","year":"2010","unstructured":"Battaglia L, Gallarate M, Cavalli R, Trotta M (2010) Solid lipid nanoparticles produced through a coacervation method. J Microencapsul 27:78\u201385","journal-title":"J Microencapsul"},{"issue":"2","key":"1403_CR16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1773-2247(12)50016-X","volume":"22","author":"L Battaglia","year":"2012","unstructured":"Battaglia L, D\u2019Addino I, Peira E, Trotta M, Gallarate M (2012) Solid lipid nanoparticles prepared by coacervation method as vehicles for ocular cyclosporine. J Drug Del Sci Technol 22(2):125\u2013130","journal-title":"J Drug Del Sci Technol"},{"key":"1403_CR17","unstructured":"Battaglia L, Trotta M, Cavalli R PCT n. WO2008 149215 A2"},{"key":"1403_CR18","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/bip.360330608","volume":"33","author":"ME Powers","year":"1993","unstructured":"Powers ME, Matsuura J, Brassell J, Manning MC, Shefter E (1993) Enhanced solubility of proteins and peptides in nonpolar solvents through hydrophobic ion pairing. Biopolymers 33:927\u2013932","journal-title":"Biopolymers"},{"key":"1403_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/132435","author":"M Gallarate","year":"2011","unstructured":"Gallarate M, Battaglia L, Peira E, Trotta M (2011) Peptide-loaded solid lipid nanoparticles prepared through coacervation technique. Int J Chem Eng. \n                    https:\/\/doi.org\/10.1155\/2011\/132435","journal-title":"Int J Chem Eng"},{"key":"1403_CR20","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1080\/02652040701532981","volume":"14","author":"L Battaglia","year":"2007","unstructured":"Battaglia L, Trotta M, Gallarate M, Chirio D (2007) Solid lipid nanoparticles formed by solvent-in-water emulsion-diffusion technique: development and influence on insulin stability. J Microencapsul 14:672\u2013684","journal-title":"J Microencapsul"},{"key":"1403_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2005.10.050","volume":"311","author":"CM Silva","year":"2006","unstructured":"Silva CM, Ribeiro AJ, Figuereido IV, Gon\u00e7alves AR, Veiga F (2006) Alginate microspheres prepared by internal gelation: development and effect on insulin stability. Int J Pharm 311:1\u201310","journal-title":"Int J Pharm"},{"issue":"9","key":"1403_CR22","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1021\/acs.jmedchem.6b01624","volume":"60","author":"M Cocco","year":"2017","unstructured":"Cocco M, Pellegrini C, Mart\u00ednez-Banaclocha H et al (2017) Development of an acrylate derivative targeting the NLRP3 inflammasome for the treatment of inflammatory bowel disease. J Med Chem 60(9):3656\u20133671","journal-title":"J Med Chem"},{"issue":"9","key":"1403_CR23","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2217\/nnm.11.52","volume":"6","author":"L Battaglia","year":"2011","unstructured":"Battaglia L, Serpe L, Muntoni E, Zara G, Trotta M, Gallarate M (2011) Methotrexate-loaded SLNs prepared by coacervation technique: in vitro cytotoxicity and in vivo pharmacokinetics and biodistribution. Nanomedicine (London) 6(9):1561\u20131573","journal-title":"Nanomedicine (London)"},{"key":"1403_CR24","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/01932691.2010.488497","volume":"32","author":"M Trotta","year":"2011","unstructured":"Trotta M, Carlotti ME, Gallarate M, Zara GP, Muntoni E, Battaglia L (2011) Insulin-loaded SLN prepared with the emulsion dilution technique. in vivo tracking of nanoparticles after oral administration to rats. J Disp Sci Technol 32:1041\u20131045","journal-title":"J Disp Sci Technol"},{"key":"1403_CR25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2337\/diab.37.2.246","volume":"37","author":"C Damg\u00e8","year":"1988","unstructured":"Damg\u00e8 C, Michel C, Aprahamian M, Couvreur P (1988) New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes 37:246\u2013250","journal-title":"Diabetes"},{"key":"1403_CR26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/A:1012076022420","volume":"14","author":"D Quintanar-Guerrero","year":"1997","unstructured":"Quintanar-Guerrero D, Allemann E, Fessi H, Doelker E (1997) Applications of the ion-pair concept to hydrophilic substances with special emphasis on peptides. Pharm Res 14:119\u2013127","journal-title":"Pharm Res"},{"key":"1403_CR27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ejmech.2006.01.013","volume":"41","author":"LP Ruan","year":"2006","unstructured":"Ruan LP, Chen S, Yu BY, Zhu DN, Cordell GA, Qiu SX (2006) Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model. Eur J Med Chem 41:605\u2013610","journal-title":"Eur J Med Chem"},{"key":"1403_CR28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.vascn.2013.06.001","volume":"68","author":"Z Luo","year":"2013","unstructured":"Luo Z, Liu Y, Zhao B et al (2013) Ex vivo and in situ approaches used to study intestinal absorption. J Pharm Toxicol Method 68:208\u2013216","journal-title":"J Pharm Toxicol Method"},{"key":"1403_CR29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s003830100592","volume":"17","author":"T Sawai","year":"2001","unstructured":"Sawai T, Drongowski RA, Lampman RW, Coran AG, Harmon CM (2001) The effect of phospholipids and fatty acids on tight junction permeability and bacterial translocation. Pediatr Surg Int 17:269\u2013274","journal-title":"Pediatr Surg Int"},{"key":"1403_CR30","first-page":"362","volume":"11","author":"G Sandri","year":"2010","unstructured":"Sandri G, Bonferoni MC, Rossi S, Ferrari F, Boselli C, Caramella C (2010) Insulin-loaded nanoparticles base on N-Trimethyl Chitosan. In Vitro (CaCo-2 Model) and Ex Vivo (Excised Rat Jejunum, Duodenum, and Ileum) evaluation of penetration enhancement properties. AAPS J 11:362\u2013371","journal-title":"AAPS J"},{"issue":"6","key":"1403_CR31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/0148607196020006406","volume":"20","author":"Y Iiboshi","year":"1996","unstructured":"Iiboshi Y, Nezu R, Khan J et al (1996) Development changes in distribution of the mucous gel layer in rat small intestine. J Parenter Enteral Nutr 20(6):406\u2013411","journal-title":"J Parenter Enteral Nutr"},{"issue":"5","key":"1403_CR32","doi-asserted-by":"crossref","first-page":"G922","DOI":"10.1152\/ajpgi.2001.280.5.G922","volume":"280","author":"C Atuma","year":"2001","unstructured":"Atuma C, Strugala V, Allen A, Holm L (2001) The adherent gastrointestinal mucous gel layer; thickness and physical state in vivo. Am J Physiol Gastrointest Liver Physiol 280(5):G922\u2013G929","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1403_CR33","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1211\/0022357011776685","volume":"53","author":"M Miyazaki","year":"2001","unstructured":"Miyazaki M, Mukai H, Iwanaga K, Morimoto K, Kakemi M (2001) Pharmacokinetic\u2013pharmacodynamic modelling of human insulin: validity of pharmacological availability as a substitute for extent of bioavailability. J Pharm Pharmacol 53:1235\u20131246","journal-title":"J Pharm Pharmacol"},{"key":"1403_CR34","doi-asserted-by":"crossref","first-page":"1800458","DOI":"10.1002\/mabi.201800458","volume":"19","author":"ZB Taraghdari","year":"2019","unstructured":"Taraghdari ZB, Imani R, Mohabatpour F (2019) A review on bioengineering approaches to insulin delivery: a pharmaceutical and engineering perspective. Macromol Biosci 19:1800458","journal-title":"Macromol Biosci"},{"key":"1403_CR35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2017.09.003","volume":"264","author":"CY Wong","year":"2017","unstructured":"Wong CY, Al-Salamia H, Dass CR (2017) Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment. J Control Release 264:247\u2013275","journal-title":"J Control Release"},{"issue":"2","key":"1403_CR36","first-page":"594","volume":"295","author":"CQ Xia","year":"2000","unstructured":"Xia CQ, Wang J, Shen WC (2000) Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats. J Pharmacol Exp Ther 295(2):594\u2013600","journal-title":"J Pharmacol Exp Ther"},{"key":"1403_CR37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/152091502760306544","volume":"4","author":"S Clement","year":"2002","unstructured":"Clement S, Still JG, Kosutic G, McAllister RG (2002) Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in Type 1 Diabetes Mellitus: the glucose stabilization effects of HIM2. Diabetes Technol Ther 4:459","journal-title":"Diabetes Technol Ther"},{"key":"1403_CR38","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1021\/bm0703923","volume":"8","author":"B Sarmento","year":"2007","unstructured":"Sarmento B, Ribeiro A, Veiga F, Ferreira D, Neufeld R (2007) Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules 8:3054\u20133060","journal-title":"Biomacromolecules"},{"key":"1403_CR39","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s11051-012-1219-4","volume":"14","author":"P Hurkat","year":"2012","unstructured":"Hurkat P, Jain A, Jain A, Shilpi S, Gulbake A, Jain SK (2012) Concanavalin A conjugated biodegradable nanoparticles for oral insulin delivery. J Nanopart Res 14:1219","journal-title":"J Nanopart Res"},{"issue":"213","key":"1403_CR40","doi-asserted-by":"crossref","first-page":"213ra167","DOI":"10.1126\/scitranslmed.3007049","volume":"5","author":"EM Pridgen","year":"2013","unstructured":"Pridgen EM, Alexis F, Kuo TT et al (2013) Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery. Sci Transl Med 5(213):213ra167","journal-title":"Sci Transl Med"},{"key":"1403_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-019-01351-4","author":"D Gordin","year":"2019","unstructured":"Gordin D, Saraheimo M, Tuomikangas J et al (2019) Insulin exposure mitigates the increase of arterial stiffness in patients with type 2 diabetes and albuminuria: an exploratory analysis. Acta Diabetol. \n                    https:\/\/doi.org\/10.1007\/s00592-019-01351-4","journal-title":"Acta Diabetol"},{"issue":"4","key":"1403_CR42","first-page":"743","volume":"2","author":"B Sarmento","year":"2007","unstructured":"Sarmento B, Martins S, Ferreira D, Souto EB (2007) Oral insulin delivery by means of solid lipid nanoparticles. Int J Nanomed 2(4):743\u2013749","journal-title":"Int J Nanomed"},{"key":"1403_CR43","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00592-017-0976-z","volume":"54","author":"S Tang","year":"2017","unstructured":"Tang S, Wu W, Tang W et al (2017) Suppression of Rho-kinase 1 is responsible for insulin regulation of the AMPK\/SREBP-1c pathway in skeletal muscle cells exposed to palmitate. Acta Diabetol 54:635\u2013644","journal-title":"Acta Diabetol"},{"key":"1403_CR44","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00592-018-1107-1","volume":"55","author":"XW Zhang","year":"2018","unstructured":"Zhang XW, Zhang XL, Xu B, Kang LN (2018) Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: a meta-analysis of randomized controlled trials. Acta Diabetol 55:429\u2013441","journal-title":"Acta Diabetol"},{"issue":"22","key":"1403_CR45","doi-asserted-by":"crossref","first-page":"10744","DOI":"10.1073\/pnas.1901967116","volume":"116","author":"J Wang","year":"2019","unstructured":"Wang J, Yu J, Zhang Y et al (2019) Glucose transporter inhibitor-conjugated insulin mitigates hypoglycaemia. PNAS 116(22):10744\u201310748","journal-title":"PNAS"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01403-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-019-01403-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01403-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T23:42:35Z","timestamp":1597102955000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-019-01403-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,12]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1403"],"URL":"https:\/\/doi.org\/10.1007\/s00592-019-01403-9","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,12]]},"assertion":[{"value":"13 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animal experiments were performed owing to Italian and International Guidelines (DL 26\/2014 implementation of directive 2010\/63 UE). An experimental protocol approved by the Turin University Bioethical Committee and the Italian Ministry of Health (Aut. N. 32\/2016-PR) was employed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study no informed consent is required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}